BiochemistryJournal of Medicinal ChemistryPeer-reviewed
FDA drug repurposing uncovers modulators of dopamine D2 receptor localization via disruption of the NCS-1 interaction
Daniel Muñoz-Reyes, Lorena Aguado, Sandra Arroyo‐Urea…·María José Sánchez-Barrena
The paper identifies FDA-approved drugs that disrupt the NCS-1/D2R interaction, modulating D2R localization without affecting its signaling.
3 citations